ANCA practice in diagnostic pathology: state of play and unresolved challenges

The ANCA Laboratory Practices Meeting, a satellite of the 22nd International Vasculitis Workshop (Melbourne, 22 February 2026), convened laboratory scientists, pathologists and clinicians to discuss current ANCA testing practices. Delegates described divergent practices. Three themes emerged. First, high-quality MPO- and PR3-ANCA immunoassays are the preferred first-line test for ANCA-associated vasculitis. At diagnosis, harmonisation of ANCA interpretation through likelihood ratios and test-result intervals may offer a practical way to improve result interpretation and comparability despite differences in analytical platforms. Second, whilst antigen-specific immunoassays have better overall test characteristics for vasculitis, they have not rendered ANCA indirect immunofluorescence (IIF) redundant. ‘Typical’ ANCA patterns add value both in supporting pattern concordance with MPO- and PR3-ANCA for ANCA-associated vasculitis, and in raising suspicion for drug-induced vasculitis when discordant. ‘Atypical’ patterns, on the other hand may be helpful in the diagnosis of autoimmune liver diseases and inflammatory bowel disease. Inter-laboratory agreement on pattern classification remains suboptimal. A classification system for ANCA IIF modelled on the International Consensus on ANA Patterns (ICAP) would be beneficial. Third, testing in low pre-test probability population consumes laboratory resources, and increases the risk of non-specific results. Choosing the appropriate indication for ANCA testing, whether diagnosis of vasculitis, monitoring of established disease, or investigation of gastrointestinal and hepatobiliary disease, ultimately rests with the requesting clinician. Laboratories can offer distinct requesting items to direct each request to the most appropriate testing algorithm. However, adaptation is limited by insufficient clinical information, costs, clinician education, and in some health systems, historical reimbursement rules.

Authors

Institutions

Publication Details

Journal
Rheumatology
Published
2026-11-18
DOI
https://doi.org/10.1093/rheumatology/keag650
Primary Topic
Vasculitis and related conditions
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

ANCA practice in diagnostic pathology: state of play and unresolved challenges

Jan G.M.C. Damoiseaux, Ulrich Specks, Andrew P McLean‐Tooke, Shaun S. C. Ho et al.
Rheumatology
Vasculitis and related conditions
article

ANCA practice in diagnostic pathology: state of play and unresolved challenges

Jan G.M.C. Damoiseaux, Ulrich Specks, Andrew P McLean‐Tooke, Shaun S. C. Ho, Christine S. Bundell, Saša Čučnik, David McDonald, Yang Tran, Kerri M. Prain, Catherine Yu
article en

Abstract

The ANCA Laboratory Practices Meeting, a satellite of the 22nd International Vasculitis Workshop (Melbourne, 22 February 2026), convened laboratory scientists, pathologists and clinicians to discuss current ANCA testing practices. Delegates described divergent practices. Three themes emerged. First, high-quality MPO- and PR3-ANCA immunoassays are the preferred first-line test for ANCA-associated vasculitis. At diagnosis, harmonisation of ANCA interpretation through likelihood ratios and test-result intervals may offer a practical way to improve result interpretation and comparability despite differences in analytical platforms. Second, whilst antigen-specific immunoassays have better overall test characteristics for vasculitis, they have not rendered ANCA indirect immunofluorescence (IIF) redundant. ‘Typical’ ANCA patterns add value both in supporting pattern concordance with MPO- and PR3-ANCA for ANCA-associated vasculitis, and in raising suspicion for drug-induced vasculitis when discordant. ‘Atypical’ patterns, on the other hand may be helpful in the diagnosis of autoimmune liver diseases and inflammatory bowel disease. Inter-laboratory agreement on pattern classification remains suboptimal. A classification system for ANCA IIF modelled on the International Consensus on ANA Patterns (ICAP) would be beneficial. Third, testing in low pre-test probability population consumes laboratory resources, and increases the risk of non-specific results. Choosing the appropriate indication for ANCA testing, whether diagnosis of vasculitis, monitoring of established disease, or investigation of gastrointestinal and hepatobiliary disease, ultimately rests with the requesting clinician. Laboratories can offer distinct requesting items to direct each request to the most appropriate testing algorithm. However, adaptation is limited by insufficient clinical information, costs, clinician education, and in some health systems, historical reimbursement rules.

Rheumatology
Royal Children's Hospital (AU), Mayo Clinic (US), University of Ljubljana (SI), The University of Melbourne (AU), The University of Western Australia (AU), Royal Prince Alfred Hospital (AU), Maastricht University Medical Centre (NL), Princess Margaret Hospital for Children (AU), Ljubljana University Medical Centre (SI), Sir Charles Gairdner Hospital (AU), Westmead Hospital (AU), Maastricht University (NL), St Vincent's Hospital Melbourne (AU), Queen Elizabeth II Medical Centre (AU), Slovenian Centre of Excellence for Space Sciences and Technologies (SI), Murdoch Children's Research Institute (AU), Pathwest Laboratory Medicine (AU)
Vasculitis and related conditions
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon